<?xml version='1.0' encoding='utf-8'?>
<document id="23624139"><sentence text="Severe water intoxication secondary to the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin: a case report and review of the literature."><entity charOffset="107-119" id="DDI-PubMed.23624139.s1.e0" text="desmopressin" /></sentence><sentence text="Most of the clinical data on the safety profile of desmopressin (DDAVP), which is an effective treatment for both polyuric conditions and bleeding disorders, originate from studies on the tailoring of drug treatment, whereas few reports exist describing severe side effects secondary to drug-drug interaction"><entity charOffset="51-63" id="DDI-PubMed.23624139.s2.e0" text="desmopressin" /><entity charOffset="65-70" id="DDI-PubMed.23624139.s2.e1" text="DDAVP" /><pair ddi="false" e1="DDI-PubMed.23624139.s2.e0" e2="DDI-PubMed.23624139.s2.e0" /><pair ddi="false" e1="DDI-PubMed.23624139.s2.e0" e2="DDI-PubMed.23624139.s2.e1" /></sentence><sentence text=" We herein describe a case of severe hyponatremia complicated by seizure and coma due to the intake of non-steroidal anti-inflammatory drugs (NSAIDs) in a patient on DDAVP replacement therapy for central diabetes insipidus (DI)"><entity charOffset="166-170" id="DDI-PubMed.23624139.s3.e0" text="DDAVP" /></sentence><sentence text=" A 50-yr-old Caucasian man, with congenital central DI, developed an episode of generalized tonic-clonic seizure, resulting in coma immediately after being admitted to the Emergency Unit for weakness and emesis" /><sentence text=" Based on his medical history and clinical findings, water intoxication secondary to ketoprofen intake (200 mg/day for the last 3 days) concomitant with DDAVP replacement therapy (Minirin(Â®) 60 mcg 4 tablets a day) was hypothesized as being the cause of the severe euvolemic hypotonic hyponatremia (natremia 113 mEq/l, plasma osmolality 238 mOsm/Kg)"><entity charOffset="85-95" id="DDI-PubMed.23624139.s5.e0" text="ketoprofen" /><entity charOffset="153-162" id="DDI-PubMed.23624139.s5.e1" text="DDAVP" /><pair ddi="false" e1="DDI-PubMed.23624139.s5.e0" e2="DDI-PubMed.23624139.s5.e0" /><pair ddi="false" e1="DDI-PubMed.23624139.s5.e0" e2="DDI-PubMed.23624139.s5.e1" /></sentence><sentence text=" After standard emergency procedures, appropriate gradual restoration of serum sodium levels to the normal range was achieved in 72 hours" /><sentence text=" Hydratation was maintained according to water excretion and desmopressin therapy was re-introduced"><entity charOffset="61-73" id="DDI-PubMed.23624139.s7.e0" text="desmopressin" /></sentence><sentence text=" We discuss this case report in the context of the published literature" /><sentence text=" The present report first highlights the potentially life-threatening side effects associated with over-the-counter NSAIDs during DDAVP replacement therapy for central DI"><entity charOffset="130-141" id="DDI-PubMed.23624139.s9.e0" text="DDAVP" /></sentence><sentence text=" Risks and benefits of co-treatment should be carefully considered and therapeutic alternatives to NSAIDs should be recommended to patients with central DI in order to improve DDAVP safety"><entity charOffset="176-180" id="DDI-PubMed.23624139.s10.e0" text="DDAVP" /></sentence><sentence text="" /></document>